Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Femasys Inc. - Common Stock
(NQ:
FEMY
)
0.3845
-0.0107 (-2.71%)
Streaming Delayed Price
Updated: 12:39 PM EDT, Apr 10, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
151,935
Open
0.3994
Bid (Size)
0.3811 (5,000)
Ask (Size)
0.3880 (200)
Prev. Close
0.3952
Today's Range
0.3811 - 0.4015
52wk Range
0.3067 - 1.290
Shares Outstanding
11,813,610
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Femasys Appoints John Canning as Chief Operating Officer to Drive Operational Execution and Advance Commercial Growth
April 01, 2026
From
Femasys Inc.
Via
GlobeNewswire
Femasys Announces Financial Results for Year Ended December 31, 2025 and Provides Corporate Update
March 31, 2026
-- Enrollment underway in FDA-authorized FINALE pivotal trial demonstrating execution toward FemBloc® U.S. approval --
From
Femasys Inc.
Via
GlobeNewswire
Performance
YTD
-39.6%
-39.6%
1 Month
-28.3%
-28.3%
3 Month
-34.9%
-34.9%
6 Month
-40.8%
-40.8%
1 Year
-67.4%
-67.4%
More News
Read More
Traders are paying attention to the gapping stocks in Monday's session.
↗
March 30, 2026
Via
Chartmill
Femasys Appoints Dr. Kenneth D. Eichenbaum to Board of Directors
March 18, 2026
From
Femasys Inc.
Via
GlobeNewswire
Femasys Advances FemBloc Toward U.S. Approval with Initiation of Pivotal Trial Enrollment
March 10, 2026
From
Femasys Inc.
Via
GlobeNewswire
Femasys Announces FemBloc® Permanent Birth Control Has Achieved MDSAP Certification, Advancing Global Market Access
February 26, 2026
From
Femasys Inc.
Via
GlobeNewswire
Femasys Receives AMA CPT Editorial Panel Approval for New Category III CPT Code for FemaSeed Intratubal Insemination
February 23, 2026
From
Femasys Inc.
Via
GlobeNewswire
Femasys Expands European Commercial Footprint with Swiss Partner for FemBloc, FemaSeed, and Portfolio Products
February 03, 2026
From
Femasys Inc.
Via
GlobeNewswire
Femasys Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement
January 14, 2026
From
Femasys Inc.
Via
GlobeNewswire
Femasys Announces Partnership with Refuah Health Center to Expand First-Line Access to FemaSeed® in Community-Based Care
January 13, 2026
From
Femasys Inc.
Via
GlobeNewswire
Traders are paying attention to the gapping stocks in Monday's session.
↗
December 29, 2025
Via
Chartmill
Femasys Secures U.S. FDA Clearance for Next-Generation FemVue Diagnostic Device
December 18, 2025
From
Femasys Inc.
Via
GlobeNewswire
Wondering what's happening in today's after-hours session?
↗
December 17, 2025
Via
Chartmill
PMCB Stock Jumps 25% After Company Sells Stake In Femasys
↗
November 25, 2025
Via
Stocktwits
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
November 17, 2025
Via
Benzinga
Femasys Announces Third Quarter Financial Results for 2025
November 14, 2025
From
Femasys Inc.
Via
GlobeNewswire
Femasys Advances Global Growth with Second Partner Order for FemBloc® in Europe
November 10, 2025
From
Femasys Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
November 10, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
November 07, 2025
Via
Benzinga
Femasys Stock Sparks Retail Frenzy After FDA Clears Final Phase Of FemBloc Trial And $58M Financing
↗
November 04, 2025
Via
Stocktwits
Femasys Secures FDA Approval to Advance Final FemBloc® Trial Phase and $12 Million Financing, with Potential to Reach $58 Million
November 03, 2025
From
Femasys Inc.
Via
GlobeNewswire
Get insights into the top gainers and losers of Friday's pre-market session.
↗
October 24, 2025
Via
Chartmill
Femasys Announces Initiation of Post-Market Surveillance Study for FemBloc® Permanent Birth Control in Europe
October 22, 2025
From
Femasys Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
↗
October 17, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
October 16, 2025
Via
Benzinga
Frequently Asked Questions
Is Femasys Inc. - Common Stock publicly traded?
Yes, Femasys Inc. - Common Stock is publicly traded.
What exchange does Femasys Inc. - Common Stock trade on?
Femasys Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Femasys Inc. - Common Stock?
The ticker symbol for Femasys Inc. - Common Stock is FEMY on the Nasdaq Stock Market
What is the current price of Femasys Inc. - Common Stock?
The current price of Femasys Inc. - Common Stock is 0.3845
When was Femasys Inc. - Common Stock last traded?
The last trade of Femasys Inc. - Common Stock was at 04/10/26 12:39 PM ET
What is the market capitalization of Femasys Inc. - Common Stock?
The market capitalization of Femasys Inc. - Common Stock is 4.54M
How many shares of Femasys Inc. - Common Stock are outstanding?
Femasys Inc. - Common Stock has 5M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
